163 related articles for article (PubMed ID: 36998430)
1. Thiopurines are an independent risk factor for active tuberculosis in inflammatory bowel disease patients.
Fortes FML; Rocha R; Santana GO
World J Gastroenterol; 2023 Mar; 29(9):1536-1538. PubMed ID: 36998430
[TBL] [Abstract][Full Text] [Related]
2. Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.
Gómez-García M; Cabello-Tapia MJ; Sánchez-Capilla AD; De Teresa-Galván J; Redondo-Cerezo E
World J Gastroenterol; 2013 Aug; 19(30):4877-86. PubMed ID: 23946592
[TBL] [Abstract][Full Text] [Related]
3. Canadian Association of Gastroenterology position statement regarding the use of thiopurines for the treatment of inflammatory bowel disease.
Marshall JK; Otley AR; Afif W; Bernstein CN; Hookey L; Leontiadis G; Panaccione R; Bressler B;
Can J Gastroenterol Hepatol; 2014; 28(7):371-2. PubMed ID: 25157527
[No Abstract] [Full Text] [Related]
4. Safety of thiopurines in the treatment of inflammatory bowel disease.
de Jong DJ; Derijks LJ; Naber AH; Hooymans PM; Mulder CJ
Scand J Gastroenterol Suppl; 2003; (239):69-72. PubMed ID: 14743886
[TBL] [Abstract][Full Text] [Related]
5. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
Kotlyar DS; Lewis JD; Beaugerie L; Tierney A; Brensinger CM; Gisbert JP; Loftus EV; Peyrin-Biroulet L; Blonski WC; Van Domselaar M; Chaparro M; Sandilya S; Bewtra M; Beigel F; Biancone L; Lichtenstein GR
Clin Gastroenterol Hepatol; 2015 May; 13(5):847-58.e4; quiz e48-50. PubMed ID: 24879926
[TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease.
Akbari M; Shah S; Velayos FS; Mahadevan U; Cheifetz AS
Inflamm Bowel Dis; 2013 Jan; 19(1):15-22. PubMed ID: 22434610
[TBL] [Abstract][Full Text] [Related]
7. Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine.
Nielsen OH; Vainer B; Rask-Madsen J
Aliment Pharmacol Ther; 2001 Nov; 15(11):1699-708. PubMed ID: 11683683
[TBL] [Abstract][Full Text] [Related]
8. Decrease in factor V activity: a new adverse effect of purine analogs in inflammatory bowel diseases?
Poupeney S; Dray X; Reignier S; Vahedi K; Alhenc M; Belluci S; Marteau P
Inflamm Bowel Dis; 2008 Jul; 14(7):1024-5. PubMed ID: 18286642
[No Abstract] [Full Text] [Related]
9. Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives.
de Boer NKH; Peyrin-Biroulet L; Jharap B; Sanderson JD; Meijer B; Atreya I; Barclay ML; Colombel JF; Lopez A; Beaugerie L; Marinaki AM; van Bodegraven AA; Neurath MF
J Crohns Colitis; 2018 Apr; 12(5):610-620. PubMed ID: 29293971
[TBL] [Abstract][Full Text] [Related]
10. Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits?
Su CG; Stein RB; Lewis JD; Lichtenstein GR
Dig Liver Dis; 2000; 32(6):518-31. PubMed ID: 11057928
[TBL] [Abstract][Full Text] [Related]
11. Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
Alexakis C; Saxena S; Chhaya V; Cecil E; Curcin V; Pollok R
Inflamm Bowel Dis; 2017 Apr; 23(4):672-680. PubMed ID: 28151735
[TBL] [Abstract][Full Text] [Related]
12. A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis.
Kennedy NA; Rhatigan E; Arnott ID; Noble CL; Shand AG; Satsangi J; Lees CW
Aliment Pharmacol Ther; 2013 Nov; 38(10):1255-66. PubMed ID: 24117596
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of thiopurine-related adverse events in elderly patients with IBD.
Calafat M; Mañosa M; Cañete F; Ricart E; Iglesias E; Calvo M; Rodríguez-Moranta F; Taxonera C; Nos P; Mesonero F; Martín-Arranz MD; Mínguez M; Gisbert JP; García-López S; de Francisco R; Gomollón F; Calvet X; Garcia-Planella E; Rivero M; Martínez-Cadilla J; Argüelles F; Arias L; Cimavilla M; Zabana Y; Domènech E;
Aliment Pharmacol Ther; 2019 Oct; 50(7):780-788. PubMed ID: 31429097
[TBL] [Abstract][Full Text] [Related]
14. Optimizing thiopurine therapy in inflammatory bowel disease.
Chevaux JB; Peyrin-Biroulet L; Sparrow MP
Inflamm Bowel Dis; 2011 Jun; 17(6):1428-35. PubMed ID: 20949566
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease.
Marion JF
Inflamm Bowel Dis; 1998 May; 4(2):116-7. PubMed ID: 9687219
[No Abstract] [Full Text] [Related]
16. Risk of skin cancers in thiopurines-treated and thiopurines-untreated patients with inflammatory bowel disease: A systematic review and meta-analysis.
Huang SZ; Liu ZC; Liao WX; Wei JX; Huang XW; Yang C; Xia YH; Li L; Ye C; Dai SX
J Gastroenterol Hepatol; 2019 Mar; 34(3):507-516. PubMed ID: 30393891
[TBL] [Abstract][Full Text] [Related]
17. Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study.
Vos AC; Bakkal N; Minnee RC; Casparie MK; de Jong DJ; Dijkstra G; Stokkers P; van Bodegraven AA; Pierik M; van der Woude CJ; Oldenburg B; Hommes DW;
Inflamm Bowel Dis; 2011 Sep; 17(9):1837-45. PubMed ID: 21830262
[TBL] [Abstract][Full Text] [Related]
18. [Optimized thiopurine treatment in chronic inflammatory bowel disease].
Kiszka-Kanowitz M; Theede K; Nielsen AM
Ugeskr Laeger; 2014 May; 176(22):. PubMed ID: 25352005
[TBL] [Abstract][Full Text] [Related]
19. Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease.
Chupin A; Perduca V; Meyer A; Bellanger C; Carbonnel F; Dong C
Aliment Pharmacol Ther; 2020 Oct; 52(8):1289-1297. PubMed ID: 32840893
[TBL] [Abstract][Full Text] [Related]
20. Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines.
Dotan I; Werner L; Vigodman S; Agarwal S; Pfeffer J; Horowitz N; Malter L; Abreu M; Ullman T; Guzner-Gur H; Halpern Z; Mayer L
Inflamm Bowel Dis; 2012 Feb; 18(2):261-8. PubMed ID: 21438101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
